SLC2A1 and urinary bladder carcinoma: Yang et al. found that miR-21 may suppress glycolytic enzymes, including GLUT-1, and suppress high glycolysis levels in bladder cancer cells via inhibition of the PI3K/Akt/mTOR pathway[35].